Go Pro

Weiss Ratings' Rating of Sol Strategies on 6/30/2026

On June 30, 2026, Weiss Ratings updated its outlook on Sol Strategies (NASDAQ:STKE) with the action "Initiated Coverage", setting a "Sell (D)" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Weiss Ratings

DateCompanyAction
7/13/2026
Voyager Therapeutics, Inc. stock logo
VYGR
Voyager Therapeutics
Reiterated Rating
7/13/2026
Universal Health Realty Income Trust stock logo
UHT
Universal Health Realty Income Trust
Reiterated Rating
7/13/2026
Ucommune International Ltd. stock logo
UK
Ucommune International
Reiterated Rating
7/13/2026
Turn Therapeutics Inc. stock logo
TTRX
Turn Therapeutics
Upgrade
7/13/2026
Texxon Holding Limited stock logo
NPT
Texxon
Upgrade
7/13/2026
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
Reiterated Rating
More Ratings From Weiss Ratings